Thomas Civik, Director at Pyxis Oncology, Inc. (PYXS), bought 15,700 shares at $12.74 ($200K) on 2021-11-18, disclosed to the SEC on 2021-11-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.